Fluor bags EPCM contract new API manufacturing facility in US

Fluor bags EPCM contract for new API manufacturing facility in US

7:30 AM, 21st December 2016
Fluor logo

IRVING, US: Fluor Corporation has been awarded an engineering, procurement, construction and management (EPCM) contract by Novo Nordisk, for its new $2 billion diabetes active pharmaceutical ingredient (API) manufacturing facility in Clayton, North Carolina.

Fluor has been providing basic design services since Novo Nordisk announced plans for the new facility in August 2015 and now will be executing the full scope of work. Fluor booked its $1.2 billion value of the investment in the fourth quarter of 2016. Construction is expected to be completed in mid-2019.

The new facility will measure more than 830,000 square feet, the equivalent of nearly seven football fields, and will produce life-saving medicines for use by patients around the world.

Nearly 2,500 craft employees and subcontractor jobs are expected at peak construction with about 700 new jobs at the facility when it is completed. Fluor participated in a groundbreaking event this past spring, and its Greenville, South Carolina office is leading the project, leveraging Fluor’s global resources as needed.

“This project is the single largest life sciences facility investment in North Carolina’s history, which fits well with Fluor’s legacy of building numerous significant life sciences and manufacturing projects in the south-east US,” said Juan Hernández, president of Fluor’s life sciences and advanced manufacturing business.

“Based on Fluor’s strong safety culture, technical competence in the life sciences industry and ability to deliver the full scope of work, we have selected them for this critical project. We look forward to continued strong cooperation for the success of this project,” added Morten Nielsen, senior VP, Novo Nordisk.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Sika to open first concrete admixture plant in Ethiopia

BAAR, SWITZERLAND: Sika AG is opening the first concrete admixture production plant in Ethiopia. Sika is the first-ever international company to manuf ...

Read more
Wacker acquires Antibioticos’ fermentation plant in Spain

MUNICH GERMANY/ LEON, SPAIN: Wacker BioSolutions, the life sciences and biotechnology division of the Wacker Group, is acquiring a large-scale ferment ...

Read more
FMC unveils new coating solution for nutraceuticals

PHILADELPHIA, US: FMC Corporation's health and nutrition business has unveiled its new Aquateric N100 enteric coating solution, a new alginate-based p ...

Read more
Krishna Antioxidants plans to commission new facility; celebrates 25 years

MUMBAI, INDIA: Krishna Antioxidants Pvt Ltd (KAPL), the leading speciality chemicals manufacturer said it has plans to commission its new facility soo ...

Read more
KBR bags 2 global engineering services contract from BP

HOUSTON, US: KBR Inc has been awarded two global contracts by BP International Limited; one for the provision of conceptual engineering services and a ...

Read more
BioAmber, CJ CheilJedang plan succinic acid JV in Asia

MONTREAL, CANADA: BioAmber Inc has signed a non-binding letter of intent with South Korean-based CJ CheilJedang Corporation (CJCJ). Under th ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X